(Q21134982)

17 August 2022

Giorgia Mori

7

Giorgia

Mori

1 reference

17 August 2022

Silvia Buroni

4

Silvia

Buroni

1 reference

17 August 2022

Laurent R Chiarelli

6

Laurent R

Chiarelli

1 reference

17 August 2022

Maria Rosalia Pasca

16

Maria Rosalia

Pasca

1 reference

17 August 2022

Priscille Brodin

12

Priscille

Brodin

1 reference

17 August 2022

Giovanna Riccardi

15

Giovanna

Riccardi

1 reference

17 August 2022

Giulia Degiacomi

2

Giulia

Degiacomi

2 references

ORCID Public Data File 2021

Ana Luisa de Jesus Lopes Ribeiro

17 August 2022

1

Ana Luisa de Jesus Lopes

Ribeiro

object named as

Ana Luisa de Jesus Lopes Ribeiro

1 reference

17 August 2022

Maria Loreto Incandela

5

Maria Loreto

Incandela

Maria Loreto Incandela

1 reference

Caterina Giovanna Valentini

17 August 2022

13

Giovanna

Valentini

Giovanna Valentini

1 reference

17 August 2022

Fanny Ewann

3

Fanny

Ewann

1 reference

17 August 2022

Jaeseung Kim

8

Jaeseung

Kim

1 reference

17 August 2022

Monica Contreras-Dominguez

9

Monica

Contreras-Dominguez

1 reference

17 August 2022

Young-Sam Park

10

Young-Sam

Park

1 reference

17 August 2022

Sung-Jun Han

11

Sung-Jun

Han

1 reference

Creative Commons Attribution 4.0 International

17 August 2022

language of work or name

English

0 references

publication date

2011

0 references

published in

PLOS One

0 references

volume

6

0 references

issue

11

0 references

page(s)

e26675

0 references

copyright license

start time

1 November 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Biological and structural characterization of the Mycobacterium smegmatis nitroreductase NfnB, and its role in benzothiazinone resistance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3206020

Decaprenylphosphoryl-β-D-ribose 2'-epimerase, the target of benzothiazinones and dinitrobenzamides, is an essential enzyme in Mycobacterium smegmatis

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3206020

High content screening identifies decaprenyl-phosphoribose 2' epimerase as a target for intracellular antimycobacterial inhibitors

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3206020

Benzothiazinones kill Mycobacterium tuberculosis by blocking arabinan synthesis

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3206020

Global incidence of multidrug-resistant tuberculosis

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3206020

Decaprenylphosphoryl arabinofuranose, the donor of the D-arabinofuranosyl residues of mycobacterial arabinan, is formed via a two-step epimerization of decaprenylphosphoryl ribose

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3206020

Decaprenylphosphoryl-β-D-ribose 2'-epimerase from Mycobacterium tuberculosis is a magic drug target

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3206020

New antituberculous drugs in development

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3206020

Mycobacterium tuberculosis: drug resistance and future perspectives

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3206020

Emergence of new forms of totally drug-resistant tuberculosis bacilli: super extensively drug-resistant tuberculosis or totally drug-resistant strains in iran.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3206020

Extensively drug-resistant tuberculosis: current challenges and threats

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3206020

Biosynthesis of D-arabinose in mycobacteria - a novel bacterial pathway with implications for antimycobacterial therapy

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3206020

Reflections on the white plague

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3206020

Benzothiazinones: prodrugs that covalently modify the decaprenylphosphoryl-β-D-ribose 2'-epimerase DprE1 of Mycobacterium tuberculosis

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3206020

Preclinical testing of new drugs for tuberculosis: current challenges

29 November 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/22069462

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1371/JOURNAL.PONE.0026675

1 reference

ADS bibcode

2011PLoSO...626675D

0 references

1 reference

1 reference

1 reference